The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: olanzapine     Quarter: 2016Q3

Total Records: 887     Number of Pages: 45

DRUGNAME PT EventCount
OLANZAPINE. Lymphocyte count increased 10
OLANZAPINE. Mental impairment 10
OLANZAPINE. Neutrophil count increased 10
OLANZAPINE. Pharyngitis 10
OLANZAPINE. Post-injection delirium sedation syndrome 10
OLANZAPINE. Red blood cell count decreased 10
OLANZAPINE. Respiratory rate increased 10
OLANZAPINE. Spine malformation 10
OLANZAPINE. Withdrawal syndrome 10
OLANZAPINE. Altered state of consciousness 9
OLANZAPINE. Cardiomyopathy 9
OLANZAPINE. Depressed level of consciousness 9
OLANZAPINE. Dyskinesia 9
OLANZAPINE. Left ventricular dysfunction 9
OLANZAPINE. Leukopenia 9
OLANZAPINE. Mania 9
OLANZAPINE. Renal failure 9
OLANZAPINE. Treatment noncompliance 9
OLANZAPINE. Tremor 9
OLANZAPINE. Unresponsive to stimuli 9

Total Records: 887     Number of Pages: 45